Apr 15 2014, 6:35am CDT | by Forbes
Based on the headlines, many might think that the sole purpose of the Medicare data (released last week) was a scavenger hunt for the “Medicare Millionaires.” There was certainly no shortage of headlines with that exact phrase.
For those so inclined, the Medicare PUF (Public Use Files) are available in two formats (here), but fair warning – the uncompressed tab delimited file containing more than 9 million records is about 1.7GB. The Excel format is divided alphabetically into 12 separate files, so that could be a little easier to work with.
The trouble, of course, is that data (any size) isn’t insight and in this case specifically, revenue isn’t profit. Large and frequent Medicare bills are often legitimate and often get processed for many providers through a single name or entity.
Also, while the data is accurate – it’s incomplete. It doesn’t include payments through private insurers, Medicaid or other passive sources of income (ie: surgical or diagnostic imaging centers), and it doesn’t include the most important element of all for true insight – quality. Using a consumer brand analogy, procedure pricing alone is like two 4-door sedans priced $20,000 apart – with no other information. Brilliant.
What it definitely does do is provide the same shock and awe we’ve seen before with Steven Brill (Bitter Pill) and Elisabeth Rosenthal’s entire series on pricing (starting here) at the New York Times. I went as far as to call pricing transparency the healthcare “Story Of The Year For 2013″ (here).
It definitely manages to capture the imagination around a hopeful (and potentially large) impact on pricing. So let’s see the shock and awe.
The list goes on. But what’s the value of this to any of us as patients – or to the much larger national need for healthcare reform? Not much.
The hope, of course, is that pricing transparency alone will unleash market forces which will fuel heated competition which will force lower prices. But hope isn’t a strategy when the system is running at over $3 trillion a year – and growing at about 5% per year for as far as the eye can see.
The most impressive patient service I’ve seen so far is the Wall Street Journal’s online search tool which returns the number of procedures performed (and billed to Medicare – paywalled here). That has some potential value for patients who can now compare the number of procedures performed (and billed to Medicare) in the broader assessment of a provider’s skill. Unfortunately, without information around outcome, it too is very shallow on real insight.
null If transparency can accelerate the debate (and reform) around actual pricing – it does have broader value. In the meantime, 9 or even 90 million records alone isn’t very insightful.
“Transparency will help – in fact it’s a prerequisite – but transparency is not going to be enough.” Steven Brill – Keynote Presentation – The National Summit on Health Care Price, Cost and Quality Transparency
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.
blog comments powered by Disqus